SCHEMBL2327658

SCHEMBL2327658

CCOC(=O)[C@@H](CS)NCC(=O)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.54
NPC1 O15118 4/20 0.54
MEN1 O00255 3/20 0.54
RAB9A P51151 3/20 0.41
MMP8 P22894 2/20 0.41
PIN1 Q13526 1/20 0.41
POLB P06746 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
SMN1; SMN2 Q16637 5/20 0.41
HPGD P15428 2/20 0.41
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
CYP3A4 P08684 1/20 0.41
ALOX15 P16050 1/20 0.41
CES1 P23141 1/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ALDH1A1 P00352 2/20 0.40
AGTR1 P30556 1/20 0.40
DPP4 P27487 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2327960 0.89 LMNA (0.49) KMT2ANPC1MEN1RAB9APOLB
SCHEMBL2329487 0.88 KMT2A (0.54) KMT2ANPC1MEN1RAB9APOLB
SCHEMBL26199653 0.87 NPC1 (0.55) KMT2ANPC1MEN1RAB9AMMP8
SCHEMBL2323847 0.82 MEN1 (0.48) KMT2ANPC1MEN1RAB9ASMN1; SMN2
SCHEMBL2331177 0.81 MMP8 (0.44) KMT2ANPC1MEN1MMP8PIN1
SCHEMBL1781525 0.79 SMN1; SMN2 (0.49) KMT2AMEN1MMP8PIN1SMN1; SMN2
SCHEMBL28186906 0.79 SMN1; SMN2 (0.49) KMT2AMEN1MMP8PIN1SMN1; SMN2
SCHEMBL1780144 0.79 SMN1; SMN2 (0.49) KMT2AMEN1MMP8PIN1SMN1; SMN2
Hydrochloric Acid SCHEMBL3366422 0.78 SMN1; SMN2 (0.48) KMT2AMEN1MMP8PIN1SMN1; SMN2
Hydrochloric Acid SCHEMBL7323482 0.78 SMN1; SMN2 (0.48) KMT2AMEN1MMP8PIN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2356979-B1 ANTI-WRINKLE AGENTS POLA CHEM IND INC (JP) 2017-10-25 EP disclosed
EP-3173063-A1 ANTI-WRINKLE AGENTS Pola Chemical Industries Inc. (JP) 2017-05-31 EP disclosed
US-8835498-B2 Anti-wrinkle agents POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-16 US disclosed
US-20110245343-A1 ANTI-WRINKLE AGENTS POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed
EP-2356979-A1 ANTI-WRINKLE AGENTS Pola Chemical Industries Inc. (JP) 2011-08-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245343-A1 ANTI-WRINKLE AGENTS GLA, H1-4, H1-3 KMT2A 3153/4885NPC1 4142/4885MEN1 4082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.